Jul 10, 2026
Ionis, AstraZeneca Stumble in ATTR-CM Trial as Rivals Stand to Gain

Ionis Pharmaceuticals Inc. (NASDAQ:IONS) and partner AstraZeneca Plc (NYSE:AZN) said on Thursday that their Phase 3 CARDIO-TTRansform study of eplontersen for transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) failed to meet its primary efficacy endpoint. • Ionis Pharmaceuticals stock is taking a hit today.…

Jul 10, 2026
T3 Defense Buys Into Israel’s Drone Industry With Project35 Majority Stake

T3 Defense Inc. (NASDAQ:DFNS) stock plunged Friday after the company announced it had acquired a 60% stake in Israeli drone and counter-UAV developer Project35, expanding its portfolio of mission-critical defense technologies. Project35 counts Israel Aerospace Industries (IAI), ELTA Systems, Rafael…

Jul 10, 2026
Catheter Precision Plunges as Traders Unwind Gains from Recent News

Catheter Precision, Inc. (NYSE:VTAK) shares plummeted on Friday as traders reversed part of the stock’s recent headline-driven gains tied to its Flyte subsidiary and new patent announcements. The decline appeared largely company-specific. The S&P 500 gained about 0.2%, while the…

Jul 10, 2026
Strategy Stock Is Trending Higher Today: What’s Going On?

Strategy Inc (NASDAQ:MSTR) shares are catching a bid Friday as bargain hunters circle a deeply beaten down name against a backdrop where most of the market is holding up reasonably well despite a slightly negative Nasdaq. Strategy Inc stock is…